A new federal law is reshaping how healthcare is paid for and delivered in America.

Dexcom generates more than $4 billion in annual revenue and has a market cap north of $30 billion, making it one of the biggest digital health companies in the world. And it all started with a better way to measure blood sugar.

More than a thousand AI medical devices have FDA clearance, yet fewer than two percent of radiologists actually use them.

When Andrew Lacy launched Prenuvo, most of the medical establishment dismissed it as fringe. Now, some of those same skeptics are collaborating with him on research.

In their first podcast since going public, Omada Health CEO Sean Duffy joins us to reflect on the journey to bend the curve of chronic disease.

What does one do after selling their company to Amazon for $1 billion? Start a new one, of course.

Most medical care is backed by varying types of evidence—yet we apply higher standards to digital health tools before they’re trusted, adopted, or reimbursed.

US healthcare has more unproductive labor and more unstructured data than any other industry, making it both especially vulnerable to disruption from generative AI and especially unprepared for it.

Over 160 million Americans are served by Optum, yet many still don’t fully understand what it actually does—or why it matters.

Women make 80% of healthcare decisions and outspend men two to one on care—yet when it comes to designing, funding, and scaling health tech, they’re still treated like a niche.